Clinical Trials
All Clinical Trials - Page 46 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02281266Phase 4Unknown
Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection
Thymosin-Alpha-1
- NCT01858051N/AWithdrawn
Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients
Ll-37
- NCT02354781Phase 1/Phase 2Completed
Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy
Follistatin
- NCT02335736Phase 2Unknown
Antagonist Protocol in IVF
Gonadorelin
- NCT02608853N/ACompleted
Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants
Liraglutide
- NCT02408705Phase 2Completed
Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
Liraglutide
- NCT02650206Phase 1Completed
Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
Liraglutide
- NCT02380521Phase 4Completed
Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
Exenatide
- NCT01969149Phase 2/Phase 3Completed
Exenatide for Stress Hyperglycemia
Exenatide
- NCT02325960Phase 4Completed
A Comparison of Exenatide and Insulin Glargine
Exenatide
- NCT02344641N/AUnknown
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
Exenatide
- NCT02507492Phase 2Unknown
RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients
Setmelanotide
- NCT02299089Phase 2Completed
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
Octreotide
- NCT02365584Phase 2Terminated
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
Lanreotide
- NCT02288377Phase 2/Phase 3Terminated
A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET)
Lanreotide
- NCT02937896N/ACompleted
Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control
Desmopressin
- NCT02340819Phase 3Completed
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)
Teduglutide
- NCT02294786Phase 2Terminated
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
Octreotide
- NCT02321878N/ACompleted
Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
Liraglutide
- NCT02305381Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
Semaglutide
- NCT02333071Phase 3Completed
1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
PT-141
- NCT02271282Phase 1Completed
Estradiol-Receptor Blockade in Older Men and Women
Sermorelin
- NCT02288130Phase 4Unknown
Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy
Gonadorelin
- NCT02238431N/AWithdrawn
Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst Transfers
Gonadorelin
- NCT03619330Phase 4Completed
Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
Liraglutide
- NCT02284230Phase 2Withdrawn
The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
Liraglutide
- NCT02313220Phase 2Completed
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
Exenatide
- NCT02288273Phase 4Completed
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
Exenatide
- NCT01860742Phase 3Withdrawn
Randomized Phase III of PRRT Versus Interferon
Octreotide
- NCT02359500Phase 1Terminated
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)
Octreotide
- NCT02335580N/ACompleted
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
Octreotide
- NCT02396966N/ACompleted
Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.
Lanreotide
- NCT02298192Phase 3Completed
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Liraglutide
- NCT06753630N/ACompleted
Polydeoxyribonucleotide for Elbow Lateral Epicondylitis
Octreotide
- NCT02049866Phase 2Completed
Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP
Teriparatide
- NCT02275338Phase 2Completed
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
Lanreotide
- NCT02314299Phase 1/Phase 2Completed
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
Elamipretide
- NCT01966978Phase 4Completed
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Liraglutide
- NCT02324842N/ACompleted
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
Liraglutide
- NCT02302976Phase 1Completed
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
Exenatide
- NCT02320045Phase 1Completed
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
Exenatide
- NCT02168491Phase 3Completed
Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
Lixisenatide
- NCT03061604N/ACompleted
RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding
Octreotide
- NCT02270983Phase 2Completed
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Linaclotide
- NCT02974244N/ACompleted
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
Exenatide
- NCT02316899Phase 3Completed
Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
Linaclotide
- NCT02203331Phase 2Completed
Bay98-7196, Dose Finding / POC Study
Gonadorelin
- NCT02254291Phase 3Completed
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
Semaglutide
- NCT02487823Phase 1Terminated
Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer
Gonadorelin
- NCT02268175Phase 2Completed
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
Gonadorelin